Clinical Trial Update: Mesenchymal Stem Cells in NPM1 Mutated Low Risk Acute Myeloid Leukemia: a Study of the Tumor Microenvironment and Its Contribution to the Outcome

View source ↗

Summary

A completed clinical trial evaluating mesenchymal stem cells in the tumor microenvironment of NPM1-mutated low-risk acute myeloid leukemia and its impact on out…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Acute Myeloid Leukaemia (AML) | Status: COMPLETED